Cargando…

Genetic Heterogeneity Between Paired Primary and Brain Metastases in Lung Adenocarcinoma

PURPOSE: About one-third of nonsmall cell lung cancer (NSCLC) patients develop brain metastases (BM). However, there is an unmet need for early diagnosis and treatment of BM. The precise mechanism for BM is still unknown. However, the genetic heterogeneity between primary tumor and paired BM indicat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Li, Liu, Zhulin, Han, Rui, Li, Lin, Wang, Mengyao, Huang, Depei, He, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450461/ https://www.ncbi.nlm.nih.gov/pubmed/32922114 http://dx.doi.org/10.1177/1179554920947335

Ejemplares similares

Heterogenous profiles between primary lung cancers and paired brain metastases reveal tumor evolution
por: Chen, Yanming, et al.
Publicado: (2023)

Genetic heterogeneity of actionable genes between primary and metastatic tumor in lung adenocarcinoma
por: Kim, Eun Young, et al.
Publicado: (2016)

Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer
por: Li, Ming, et al.
Publicado: (2018)

An active treatment of lung adenocarcinoma cancer with brain metastases: icotinib
por: Zhang, Ying, et al.
Publicado: (2015)

Genetic profiling of primary and secondary tumors from patients with lung adenocarcinoma and bone metastases reveals targeted therapy options
por: Huang, Long, et al.
Publicado: (2020)

Comparative analysis of single-cell transcriptome reveals heterogeneity in the tumor microenvironment of lung adenocarcinoma and brain metastases
por: Liang, Jialu, et al.
Publicado: (2023)

Proteomic analysis of brain metastatic lung adenocarcinoma reveals intertumoral heterogeneity and specific alterations associated with the timing of brain metastases
por: Woldmar, N., et al.
Publicado: (2022)

Heterogeneity of neoantigen landscape between primary lesions and their matched metastases in lung cancer
por: Jiang, Tao, et al.
Publicado: (2020)

Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases
por: De Mattos-Arruda, Leticia, et al.
Publicado: (2018)

Genetic and immune characteristics of multiple primary lung cancers and lung metastases
por: Yang, Ronghua, et al.
Publicado: (2021)

Single-Cell Profiling Comparisons of Tumor Microenvironment between Primary Advanced Lung Adenocarcinomas and Brain Metastases and Machine Learning Algorithms in Predicting Immunotherapeutic Responses
por: Wu, Yijun, et al.
Publicado: (2023)

Clinicopathological and genetic characteristics associated with brain metastases from lung adenocarcinoma and utility as prognostic factors
por: Kobayashi, Hiromasa, et al.
Publicado: (2018)

A Comparison of DNA Mutation and Copy Number Profiles of Primary Breast Cancers and Paired Brain Metastases for Identifying Clinically Relevant Genetic Alterations in Brain Metastases
por: Tyran, Marguerite, et al.
Publicado: (2019)

Genetic profiling of circulating cell‐free DNA from cerebrospinal fluid and paired plasma in ALK‐positive lung cancer with brain metastases
por: Shi, Liang, et al.
Publicado: (2023)

Icotinib as initial treatment in lung adenocarcinoma patients with brain metastases
por: Xu, Jian‐ping, et al.
Publicado: (2016)

Lack of Genomic Heterogeneity at High-Resolution aCGH between Primary Breast Cancers and Their Paired Lymph Node Metastases
por: Vollebergh, Marieke A., et al.
Publicado: (2014)

Upfront whole brain radiotherapy for multiple brain metastases in patients with EGFR-mutant lung adenocarcinoma
por: Li, Changhui, et al.
Publicado: (2019)

Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases
por: He, Yayi, et al.
Publicado: (2016)

Detection of EGFR Mutations in Cerebrospinal Fluid of EGFR-Mutant Lung Adenocarcinoma With Brain Metastases
por: Shi, Liang, et al.
Publicado: (2021)

Heterogeneity of tumor immune microenvironment of EGFR/ALK-positive tumors versus EGFR/ALK-negative tumors in resected brain metastases from lung adenocarcinoma
por: Xiao, Gang, et al.
Publicado: (2023)

Applicability of graded prognostic assessment of lung cancer using molecular markers to lung adenocarcinoma patients with brain metastases
por: Li, Hongwei, et al.
Publicado: (2017)

Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma
por: Hua, Xing, et al.
Publicado: (2020)

Adenocarcinoma of the Lung with Miliary Metastases and Primary Resistance Exon 20 Mutations
por: Hsu, Fred
Publicado: (2018)

Development and validation a radiomics nomogram for diagnosing occult brain metastases in patients with stage IV lung adenocarcinoma
por: Cong, Ping, et al.
Publicado: (2021)

Specific organ metastases and prognosis in lung adenocarcinoma
por: Zhao, Ziran, et al.
Publicado: (2023)

Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma
por: Xu, Jianping, et al.
Publicado: (2016)

Recurrence benefit from supramarginal resection in brain metastases of lung adenocarcinoma
por: Gong, Weizhao, et al.
Publicado: (2022)

Associated Factors of Spontaneous Hemorrhage in Brain Metastases in Patients with Lung Adenocarcinoma
por: Kim, Song Soo, et al.
Publicado: (2023)

Mutational signatures of synchronous and metachronous brain metastases from lung adenocarcinoma
por: Chen, Jianing, et al.
Publicado: (2023)

Genomic comparison between cerebrospinal fluid and primary tumor revealed the genetic events associated with brain metastasis in lung adenocarcinoma
por: Deng, Zhiyong, et al.
Publicado: (2021)

Case Report: Dacomitinib is effective in lung adenocarcinoma with rare EGFR mutation L747P and brain metastases
por: Li, Yibin, et al.
Publicado: (2022)

Immune suppressive microenvironment in brain metastatic non-small cell lung cancer: comprehensive immune microenvironment profiling of brain metastases versus paired primary lung tumors (GASTO 1060)
por: Li, Meichen, et al.
Publicado: (2022)

Genomic Features of Organ-Specific Metastases in Lung Adenocarcinoma
por: Feng, Alei, et al.
Publicado: (2022)

Genomic variations in paired normal controls for lung adenocarcinomas
por: Qu, Li-Wei, et al.
Publicado: (2017)

Intensity-modulated radiation therapy combined with concomitant temozolomide for brain metastases from lung adenocarcinoma
por: Li, Jinli, et al.
Publicado: (2018)

Cutaneous Metastases from Lung Adenocarcinoma
por: Wang, Yu, et al.
Publicado: (2020)

Hepatoid Adenocarcinoma Of The Lung Metastasizing To The Gingiva
por: Wang, Chunhua, et al.
Publicado: (2019)

Prognostic model for brain metastases from lung adenocarcinoma identified with epidermal growth factor receptor mutation status
por: Li, Hongwei, et al.
Publicado: (2017)

Network-guided search for genetic heterogeneity between gene pairs
por: Gumpinger, Anja C, et al.
Publicado: (2020)

Molecular and Functional Heterogeneity of Primary Pancreatic Neuroendocrine Tumors and Metastases
por: Guo, Yiying, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dpg0i43ooeb1d93v8he5l5n2dt